Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
Atkins, Michael B, Plimack, Elizabeth R, Puzanov, Igor, Fishman, Mayer N, McDermott, David F, Cho, Daniel C, Vaishampayan, Ulka, George, Saby, Olencki, Thomas E, Tarazi, Jamal C, Rosbrook, Brad, Fernandez, Kathrine C, Lechuga, Mariajose, Choueiri, Toni K
Published in The lancet oncology (01.03.2018)
Published in The lancet oncology (01.03.2018)
Get full text
Journal Article
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Choueiri, Toni K, Fishman, Mayer N, Escudier, Bernard, McDermott, David F, Drake, Charles G, Kluger, Harriet, Stadler, Walter M, Perez-Gracia, Jose Luis, McNeel, Douglas G, Curti, Brendan, Harrison, Michael R, Plimack, Elizabeth R, Appleman, Leonard, Fong, Lawrence, Albiges, Laurence, Cohen, Lewis, Young, Tina C, Chasalow, Scott D, Ross-Macdonald, Petra, Srivastava, Shivani, Jure-Kunkel, Maria, Kurland, John F, Simon, Jason S, Sznol, Mario
Published in Clinical cancer research (15.11.2016)
Published in Clinical cancer research (15.11.2016)
Get full text
Journal Article
Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial
Rini, Brian I, Prof, Melichar, Bohuslav, Prof, Ueda, Takeshi, Prof, Grünwald, Viktor, MD, Fishman, Mayer N, Prof, Arranz, José A, MD, Bair, Angel H, PhD, Pithavala, Yazdi K, PhD, Andrews, Glen I, MS, Pavlov, Dmitri, PhD, Kim, Sinil, MD, Jonasch, Eric, MD
Published in The lancet oncology (01.11.2013)
Published in The lancet oncology (01.11.2013)
Get full text
Journal Article
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study
Powles, Thomas, O'Donnell, Peter H, Massard, Christophe, Arkenau, Hendrik-Tobias, Friedlander, Terence W, Hoimes, Christopher J, Lee, Jae Lyun, Ong, Michael, Sridhar, Srikala S, Vogelzang, Nicholas J, Fishman, Mayer N, Zhang, Jingsong, Srinivas, Sandy, Parikh, Jigar, Antal, Joyce, Jin, Xiaoping, Gupta, Ashok K, Ben, Yong, Hahn, Noah M
Published in JAMA oncology (14.09.2017)
Published in JAMA oncology (14.09.2017)
Get more information
Journal Article
A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma
Hutson, Thomas E., Michaelson, M. Dror, Kuzel, Timothy M., Agarwal, Neeraj, Molina, Ana M., Hsieh, James J., Vaishampayan, Ulka N., Xie, Ran, Bapat, Urmi, Ye, Weifei, Jain, Rohit K., Fishman, Mayer N.
Published in European urology (01.08.2021)
Published in European urology (01.08.2021)
Get full text
Journal Article
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison
Gonzalez, Brian D, Jim, Heather S L, Booth-Jones, Margaret, Small, Brent J, Sutton, Steven K, Lin, Hui-Yi, Park, Jong Y, Spiess, Philippe E, Fishman, Mayer N, Jacobsen, Paul B
Published in Journal of clinical oncology (20.06.2015)
Published in Journal of clinical oncology (20.06.2015)
Get full text
Journal Article
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
Youn, Je-In, Kumar, Vinit, Collazo, Michelle, Nefedova, Yulia, Condamine, Thomas, Cheng, Pingyan, Villagra, Alejandro, Antonia, Scott, McCaffrey, Judith C, Fishman, Mayer, Sarnaik, Amod, Horna, Pedro, Sotomayor, Eduardo, Gabrilovich, Dmitry I
Published in Nature immunology (01.03.2013)
Published in Nature immunology (01.03.2013)
Get full text
Journal Article
Effects of Notch Signaling on Regulation of Myeloid Cell Differentiation in Cancer
PINGYAN CHENG, KUMAR, Vinit, HAO LIU, YOUN, Je-In, FISHMAN, Mayer, SHERMAN, Simon, GABRILOVICH, Dmitry
Published in Cancer research (Chicago, Ill.) (01.01.2014)
Published in Cancer research (Chicago, Ill.) (01.01.2014)
Get full text
Journal Article
Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial
Atkins, Michael B., Plimack, Elizabeth R., Puzanov, Igor, Fishman, Mayer N., McDermott, David F., Cho, Daniel C., Vaishampayan, Ulka, George, Saby, Tarazi, Jamal C., Duggan, William, Perini, Rodolfo, Thakur, Mahgull, Fernandez, Kathrine C., Choueiri, Toni K.
Published in European journal of cancer (1990) (01.03.2021)
Published in European journal of cancer (1990) (01.03.2021)
Get full text
Journal Article
Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia
Gonzalez, Brian D., Small, Brent J., Cases, Mallory G., Williams, Noelle L., Fishman, Mayer N., Jacobsen, Paul B., Jim, Heather S.L.
Published in Cancer (01.02.2018)
Published in Cancer (01.02.2018)
Get full text
Journal Article
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
Buchbinder, Elizabeth I, Dutcher, Janice P, Daniels, Gregory A, Curti, Brendan D, Patel, Sapna P, Holtan, Shernan G, Miletello, Gerald P, Fishman, Mayer N, Gonzalez, Rene, Clark, Joseph I, Richart, John M, Lao, Christopher D, Tykodi, Scott S, Silk, Ann W, McDermott, David F
Published in Journal for immunotherapy of cancer (18.02.2019)
Published in Journal for immunotherapy of cancer (18.02.2019)
Get full text
Journal Article
Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma
Martini, Jean-François, Plimack, Elizabeth R, Choueiri, Toni K, McDermott, David F, Puzanov, Igor, Fishman, Mayer N, Cho, Daniel C, Vaishampayan, Ulka, Rosbrook, Bradley, Fernandez, Kathrine C, Tarazi, Jamal C, George, Saby, Atkins, Michael B
Published in Clinical cancer research (01.11.2020)
Published in Clinical cancer research (01.11.2020)
Get full text
Journal Article
Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer
Dorff, Tanya B., Longmate, Jeff A., Pal, Sumanta K., Stadler, Walter M., Fishman, Mayer N., Vaishampayan, Ulka N., Rao, Amol, Pinksi, Jacek K., Hu, James S., Quinn, David I., Lara, Primo N.
Published in Cancer (01.12.2017)
Published in Cancer (01.12.2017)
Get full text
Journal Article
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
MIRZA, Noweeda, FISHMAN, Mayer, FRICKE, Ingo, DUNN, Mary, NEUGER, Anthony M, FROST, Timothy J, LUSH, Richard M, ANTONIA, Scott, GABRILOVICH, Dmitry I
Published in Cancer research (Chicago, Ill.) (15.09.2006)
Published in Cancer research (Chicago, Ill.) (15.09.2006)
Get full text
Journal Article
Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison
Donovan, Kristine A., Gonzalez, Brian D., Nelson, Ashley M., Fishman, Mayer N., Zachariah, Babu, Jacobsen, Paul B.
Published in Psycho-oncology (Chichester, England) (01.01.2018)
Published in Psycho-oncology (Chichester, England) (01.01.2018)
Get full text
Journal Article
Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison
Nelson, Ashley M., Gonzalez, Brian D., Jim, Heather S. L., Cessna, Julie M., Sutton, Steven K., Small, Brent J., Fishman, Mayer N., Zachariah, Babu, Jacobsen, Paul B.
Published in Supportive care in cancer (01.10.2016)
Published in Supportive care in cancer (01.10.2016)
Get full text
Journal Article
Phase I Trial of Histone Deacetylase Inhibition by Valproic Acid Followed by the Topoisomerase II Inhibitor Epirubicin in Advanced Solid Tumors: A Clinical and Translational Study
MÜNSTER, Pamela, MARCHION, Douglas, CHIAPPORI, Alberto, LUSH, Richard, SULLIVAN, Daniel, DAUD, Adil, BICAKU, Elona, SCHMITT, Morgen, JI HYUN LEE, DECONTI, Ronald, SIMON, George, FISHMAN, Mayer, MINTON, Susan, GARRETT, Chris
Published in Journal of clinical oncology (20.05.2007)
Published in Journal of clinical oncology (20.05.2007)
Get full text
Journal Article